Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Drug Discount Agreements For The Active Ingredient Brodalumab, Atc L04ac12, 67304 Eisenberg Rhineland-palatinate 2026-04-15
Germany Open House Drug Discount Agreements For The Active Ingredient Fondaparinux, Atc B01ax05, 67304 Eisenberg Rhineland-palatinate 2026-04-15
Germany Open House Drug Discount Agreements For The Active Ingredient Rotigotine, Atc N04bc09, 67304 Eisenberg Rhineland-palatinate 2026-04-15
Germany Open House Drug Discount Agreements For The Active Ingredient Everolimus, Atc L04ah02, 67304 Eisenberg Rhineland-palatinate 2026-04-15
Germany Open House Drug Discount Agreements For The Active Ingredient Rotigotine, Atc N04bc09, 67304 Eisenberg Rhineland-palatinate 2026-04-15
Germany Open House Drug Discount Agreements For The Active Ingredient Brodalumab, Atc L04ac12, 67304 Eisenberg Rhineland-palatinate 2026-04-15
Germany Open House Drug Discount Agreements Pegfilgrastim, Atc L03aa13 2026-04-15
Germany Openhouse Biological Abatt Agreements 202528 Abatacept 2026-04-15
Germany The Conclusion Of A Non-exclusive Discount Agreement Pursuant To § 130a Abs.8 Sgb V On The Active Substance Sumatriptan (except Film Tablets And Tablets), Atc N02cc01 For The Period 01.12.2025 - 30.11.2027 2026-04-15
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Tocilizumab For The Period From 01.12.2025 To 30.11.2027. Tocilizumab, Fertigspritze, Fertigpen 2026-04-15
Whats app